Press release
Cardiac Resynchronization Therapy Market Surges as Heart Failure Cases Rise and Device Innovation 2025-2032 | Major Companies - Medtronic, Plc, Abbott, Biotronik, Medico S.P.A.
Cardiac Resynchronization Therapy Market
The Cardiac Resynchronization Therapy Market is expected to grow at a CAGR of 5.5% during the forecasting period 2024-2031.
The Cardiac Resynchronization Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/cardiac-resynchronization-therapy-market?sz
The Cardiac Resynchronization Therapy (CRT) Market refers to the global industry involved in the development, manufacturing, and commercialization of devices and therapies designed to improve heart function in patients with heart failure and cardiac conduction abnormalities. CRT devices synchronize the heart's ventricles, enhancing cardiac efficiency, reducing symptoms, and improving quality of life, driving growing adoption across hospitals and clinics worldwide.
Recent Key Developments of United States:
✅ November 2025: Medtronic issued a safety notice on December 1 regarding certain ICDs and CRT-D devices, highlighting ongoing vigilance in device performance amid market growth projections to USD 5.26 billion by 2035.
✅ October 2025: Texas Cardiac Arrhythmia Institute completed the first U.S. implants of the FDA-approved TCAI leadless CRT system on July 21, with commercialization ramping up in late 2025 to address non-responders to traditional therapy.
✅ September 2025: FDA issued a PMA supplement (S003) for EBR Systems' leadless CRT system on October 3, following initial approval earlier in the year, advancing wireless pacing options for heart failure patients.
Recent Key Developments of Europe:
✅ November 2025: European HTA Regulation initiated joint clinical assessments for advanced therapies like CRT starting January 2025, with phased implementation impacting pricing and reimbursement across member states.
✅ October 2025: National Institute for Health and Care Research (NIHR) in England released Med Tech-related HTA assessments on November 3, evaluating CRT technologies as part of broader healthcare reforms influencing device uptake.
✅ September 2025: Germany advanced CRT device adoption through collaborations on connected smart systems, supporting market growth amid robust reimbursement policies and rising geriatric heart failure cases.
List of the Key Players in the Cardiac Resynchronization Therapy Market:
Medtronic, Plc
Abbott
Boston Scientific Corporation
Microport Scientific Corporation
Biotronik
LEPU MEDICAL Technology Co.Ltd
Medico S.P.A
SHREE Pacetronix Ltd
Livanova PLC
Oscor Inc
Osypka Medical GmbH
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cardiac-resynchronization-therapy-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the Cardiac Resynchronization Therapy Market:
By Type: Cardiac Resynchronization Therapy Defibrillator, Cardiac Resynchronization Therapy Pacemaker.
By Application: Intraventricular Desynchrony, Interventricular Desynchrony, Atrioventricular Desynchrony.
By End-user: Hospitals, Ambulatory surgical centers, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=cardiac-resynchronization-therapy-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Cardiac Resynchronization Therapy market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Cardiac Resynchronization Therapy Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global Cardiac Resynchronization Therapy market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Cardiac Resynchronization Therapy Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Cardiac Resynchronization Therapy Market in 2025?
◆ What is the projected growth rate of the Cardiac Resynchronization Therapy Market through 2033?
◆ Who are the key players in the Cardiac Resynchronization Therapy Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Resynchronization Therapy Market Surges as Heart Failure Cases Rise and Device Innovation 2025-2032 | Major Companies - Medtronic, Plc, Abbott, Biotronik, Medico S.P.A. here
News-ID: 4326501 • Views: …
More Releases from DataM Intelligence 4Market Research
Controlled Release Fertilizers Market is projected to reach USD 4,288.4 million …
Market Size and Growth:
The Global Controlled Release Fertilizers Market size reached USD 1,852.2 million in 2022 and is projected to witness lucrative growth by reaching up to USD 4,288.4 million by 2031. The Market is expected to exhibit a CAGR of 11.3% during the forecast period (2024-2031).
The Controlled Release Fertilizers Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges.…
Smart Manufacturing Market Set to Revolutionize Industry 4.0: Innovations, Growt …
Market Overview:
The Smart Manufacturing Market is expected to grow at a CAGR of 10% during the forecasting period 2024-2031.
The Smart Manufacturing Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it…
Cell Isolation Market Set to Transform Biomedical Research: Trends, Innovations, …
Market Overview:
The Cell Isolation Market is expected to grow at a CAGR of 17.2% during the forecasting period (2024-2031).
The Cell Isolation Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it…
Ethylene Oxide Market Set to Soar: Key Trends, Growth Drivers, and Future Opport …
Market Overview:
The Global Ethylene Oxide Market is estimated to grow at a CAGR Of 3.2% during the forecast period 2024-2031.
The Ethylene Oxide Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods,…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
